Literature DB >> 11370710

Taurocholic acid-induced secretion in normal and cystic fibrosis mouse ileum.

J Hardcastle1, P T Hardcastle, J Chapman, C J Taylor.   

Abstract

Bile acids cause secretion throughout the intestinal tract and this process contributes to maintaining the fluidity of intestinal contents. In cystic fibrosis (CF) defective intestinal secretion can lead to excessive dehydration of the luminal contents and the development of clinical symptoms. This study was designed to investigate bile acid-induced secretion in mouse ileum and to determine whether this process was defective in CF. Taurocholic acid-induced secretion was monitored as a rise in short-circuit current (SCC) in ileal sheets from normal (Swiss MF1) and transgenic CF mice. Taurocholic acid increased the SCC in both intact and stripped ileal sheets from Swiss MF1 mice. This effect was due to a stimulation of electrogenic Cl- secretion as it was inhibited by Cl(-)-free conditions, serosal furosemide (frusemide), mucosal diphenylamine-2-carboxylic acid (DPC) and increased serosal K+ concentration, without being affected by reduced mucosal Na+ concentration. Taurocholic acid-induced secretion was inhibited by tetrodotoxin, indicating the involvement of a neural pathway, but this did not include capsaicin-sensitive afferent neurons or muscarinic cholinoreceptors. Mucosal mast cells also contributed to the response. Responses in tissues from transgenic wild-type mice were similar to those obtained with Swiss MF1 animals, but ilea from CF mice exhibited a lower basal SCC with significantly reduced secretory responses to acetylcholine and taurocholic acid. We concluded that taurocholic acid induces ileal secretion by a mechanism that entails activation of enteric nerves and degranulation of mucosal mast cells. Impaired bile acid-induced secretion in CF may contribute to luminal dehydration.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11370710     DOI: 10.1211/0022357011775839

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  5 in total

Review 1.  Bile salt diarrhea.

Authors:  Bruce W Robb; Jeffrey B Matthews
Journal:  Curr Gastroenterol Rep       Date:  2005-10

2.  Systemic phosphatidylcholine pretreatment protects canine esophageal mucosa during acute experimental biliary reflux.

Authors:  Gabor Eros; Jozsef Kaszaki; Miklos Czobel; Mihaly Boros
Journal:  World J Gastroenterol       Date:  2006-01-14       Impact factor: 5.742

Review 3.  Intestinal bile acid physiology and pathophysiology.

Authors:  Olga Martinez-Augustin; Fermin Sanchez de Medina
Journal:  World J Gastroenterol       Date:  2008-10-07       Impact factor: 5.742

4.  Ursodeoxycholate inhibits mast cell activation and reverses biliary injury and fibrosis in Mdr2-/- mice and human primary sclerosing cholangitis.

Authors:  Fanyin Meng; Lindsey Kennedy; Laura Hargrove; Jennifer Demieville; Hannah Jones; Taronish Madeka; Allen Karstens; Kevin Chappell; Gianfranco Alpini; Amelia Sybenga; Pietro Invernizzi; Francesca Bernuzzi; Sharon DeMorrow; Heather Francis
Journal:  Lab Invest       Date:  2018-08-24       Impact factor: 5.662

5.  Analysis of the Ability of Capsaicin to Modulate the Human Gut Microbiota In Vitro.

Authors:  Karley K Mahalak; Jamshed Bobokalonov; Jenni Firrman; Russell Williams; Bradley Evans; Brian Fanelli; Jason W Soares; Masuko Kobori; LinShu Liu
Journal:  Nutrients       Date:  2022-03-18       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.